Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.001 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.44 | 0.006 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.006 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |